UnratedDrug recall · FDA · Published September 20, 2022
QuVa Pharma Oxytocin IV Solution Recall: Incorrect Sodium Chloride Concentration
QuVa Pharma recalls oxyTOCIN 30 Units/500mL IV solution due to incorrect sodium chloride concentration (0.45% instead of 0.9%). This compounded product for institutional use may cause complications if administered improperly.
“QuVa Pharma Oxytocin IV Solution Recall: Incorrect Sodium Chloride Concentration.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34319-quva-pharma-oxytocin-iv-solution-recall-incorrect-sodium-chloride-concentration. Based on FDA recall #D-1544-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1544-2022%22&limit=1).
The FDA announced on September 20, 2022, that QuVa Pharma, Inc. recalled oxyTOCIN due to incorrect product formulation. The hazard involves the drug being added to 0.45% Sodium Chloride instead of the labeled 0.9% Sodium Chloride.
How to tell if you have it
Brand: QuVa Pharma
Product: oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to Sodium Chloride, Injection for IV Use
NDC: 70092-1068-07
Lot: 30027403
BUD: 11/14/2022
Quantity: 1994 bags
The hazard
The recall addresses the incorrect product formulation where Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) rather than the specified 0.9% Sodium Chloride (500mL).
Context
GovInfoNow's records show QuVa Pharma, Inc. has 9 other recalls on record since March 30, 2016. Other recent recalls of similar products include QuVa Pharma Recalls Methohexital Sodium Due to Impurity Failures (June 24, 2026), QuVa Pharma Recalls R.E.C.K. Injection Due to Particulate Matter (October 10, 2025), and QuVa Pharma Fentanyl Citrate Bupivacaine Solution Recall: Lack of Sterility Assurance (March 6, 2025).
How to tell if you have this one
Look for the product name 'oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use'. Check the lot number 30027403 with a batch date of 11/14/2022.
Brand
QuVa Pharma
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the lot number and batch date on the product label to confirm if it matches lot 30027403 with a batch date of 11/14/2022.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 5 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1544-2022 (September 20, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1544-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.